نتایج جستجو برای: aml

تعداد نتایج: 12334  

Journal: :The Journal of biological chemistry 2012
Nina Vitashenkova Jesper Bonnet Moeller Rikke Leth-Larsen Anders Schlosser Kit Peiter Lund Ida Tornøe Lars Vitved Søren Hansen Anthony Willis Alexandra D Kharazova Karsten Skjødt Grith Lykke Sorensen Uffe Holmskov

We have isolated a novel type of lectin named Arenicola marina lectin-1 (AML-1) from the lugworm A. marina. The lectin was purified from the coelomic fluid by affinity chromatography on a GlcNAc-derivatized column and eluted with GlcNAc. On SDS-PAGE, AML-1 showed an apparent molecular mass of 27 and 31 kDa in the reduced state. The N-terminal amino acid sequences were identical in these two ban...

Journal: :Blood 1989
R Delwel C van Buitenen M Salem F Bot S Gillis K Kaushansky B Altrock B Löwenberg

In this study, we further established the role of interleukin-1 (IL-1) alpha and IL-1 beta as regulators of proliferation of acute myeloid leukemia (AML) cells. IL-1 stimulated tritiated thymidine (3H-TdR) uptake of AML cells in 13 of 28 cases. Cytogenetic analysis confirmed the leukemic clonality of the IL-1-stimulated cells. Most likely, IL-1 exerted these stimulative effects directly on AML ...

2014
Shuang Qu Bin Liu Xiaoling Guo Hongshun Shi Meifeng Zhou Li Li Shulan Yang Xiuzhen Tong Haihe Wang

BACKGROUND Internal tandem duplication of FMS-like tyrosine kinase (FLT3-ITD) is well known to be involved in acute myeloid leukemia (AML) progression, but FLT3-ITD-negative AML cases account for 70% to 80% of AML, and the mechanisms underlying their pathology remain unclear. This study identifies protein tyrosine phophatase PRL-3 as a key mediator of FLT3-ITD-negative AML. METHODS A total of...

2013
Walentyna Balwierz Katarzyna Pawinska-Wasikowska Tomasz Klekawka Malgorzata Czogala Michal Matysiak Barbara Fic-Sikorska Elzbieta Adamkiewicz-Drozynska Lucyna Maciejka-Kapuscinska Alicja Chybicka Kinga Potocka Jacek Wachowiak Jolanta Skalska-Sadowska Jerzy Kowalczyk Beata Wojcik Mariusz Wysocki Sylwia Koltan Maryna Krawczuk-Rybak Katarzyna Muszynska-Roslan Wojciech Mlynarski Malgorzata Stolarska Tomasz Urasinski Elzbieta Kamienska Tomasz Szczepanski Renata Tomaszewska Grazyna Sobol Agnieszka Mizia-Malarz Grazyna Karolczyk Joanna Podhorecka Maria Wieczorek Irena Karpinska-Derda Wanda Badowska Angelina Moryl-Bujakowska

BACKGROUND Since 1983 four consecutive unified regimens: acute myeloid leukemia-Polish pediatric leukemia/lymphoma study group (AML-PPLLSG) 83, AML-PPLLSG 94, AML-PPLLSG 98 and AML-BFM 2004 Interim, for AML have been conducted by the Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG). In this paper, we review four successive studies on the basis of acute myeloid leukemia-Berlin-Frankfurt-M...

Journal: :Blood 1996
W Terpstra R E Ploemacher A Prins K van Lom K Pouwels A W Wognum G Wagemaker B Löwenberg J J Wielenga

A subset of leukemic cells is assumed to maintain long-term growth of acute myeloid leukemia (AML) in vivo. Characterization of these AML progenitor cells may further define growth properties of human leukemia. In vitro incubations with 5-fluorouracil (5-FU) have been used for enrichment of normal primitive hematopoietic stem cells. By analogy to normal hematopoiesis, it was hypothesized that p...

Journal: :journal of medical signals and sensors 0
fatemeh kazemi tooraj abbasian najafabadi babak nadjar araabi

acute myelogenous leukemia (aml) is a subtype of acute leukemia, which is characterized by the accumulation of myeloid blastsin the bone marrow. careful microscopic examination of stained blood smear or bone marrow aspirate is still the most significantdiagnostic methodology for initial aml screening and considered as the first step toward diagnosis. it is time-consuming and dueto the elusive n...

Journal: :Egyptian Journal of Medical Human Genetics 2023

Abstract Background Acute myeloid leukemia (AML) is a heterogeneous disorder encompassing set of hematopoietic tumors that develop when the precursor cells undergo disproportionate clonal proliferation. Homeobox A 9 ( HOXA9 ) pioneer transcription factor in AML pathogenesis along with its cofactor ecotropic integration site 1 MEIS1 ). Our work aimed to evaluate different expression levels and g...

Journal: :Hemato 2021

Acute myeloid leukemia (AML) is a heterogeneous aggressive hematologic malignancy derived from malignant clones that promote their own growth and survival at the expense of normal hematopoiesis resulting in life-threatening bleeding infections. Traditional initial AML therapy has been centered on backbone intensive chemotherapy often composed an anthracycline cytarabine. This strategy proven mo...

2016
Pankit Vachhani Jason H Mendler Andrew Evans George Deeb Petr Starostik Paul K Wallace Eunice S Wang

Spontaneous remission (SR) of acute myeloid leukemia (AML) is a very rare phenomenon. AML characterized by FLT3 internal tandem duplication (FLT3 ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantation. We report here the first case of SR of FLT3 ITD mutant AML in the literature. Our patient wa...

2017
Yan Li Qingyu Xu Na Lv Lili Wang Hongmei Zhao Xiuli Wang Jing Guo Chongjian Chen Yonghui Li Li Yu

Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. AML is a heterogeneous malignancy characterized by distinct genetic and epigenetic abnormalities. Recent genome-wide DNA methylation studies have highlighted an important role of dysregulated methylation signature in AML from biological and clinical standpoint. In this review, we will outline the recent advances i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید